| Name | Title | Contact Details |
|---|---|---|
Cristi Stein |
Vice President Growth Marketing | Profile |
Intra-Cellular Therapies is a biopharmaceutical company developing novel drugs, leveraging technology from the lab of Nobel laureate Dr. Paul Greengard, for the treatment of neuropsychiatric and neurodegenerative diseases. The Company is developing its lead drug candidate, lumateperone, a first-in-class molecule, which is in Phase 3 clinical development for the treatment of schizophrenia, bipolar depression, and agitation associated with dementia, including Alzheimer`s disease. The Company is also utilizing its phosphodiesterase (PDE) platform and other proprietary chemistry platforms to develop drugs for the treatment of CNS and other disorders. The lead compound in the PDE platform, ITI-214, a PDE1 inhibitor is being developed for the treatment of CNS and non-CNS indications.
Rhoads Pharmacy is a Hummelstown, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Novel therapeutics for metabolic and endocrine disorders
As America’s largest independent cardiac care practice, CCP is home to the most experienced cardiologists in the Philadelphia region.
Xpress Wellness provides urgent care, primary care, and occupational medicine. Walk in, check in online, or schedule a virtual visit today.